Organogenesis Holdings Inc. SEC filings ORGO
Organogenesis Holdings Inc. has 673 filings in SEC EDGAR's recent list, going back to Dec 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2024 | — |
| S-3 | Shelf registration | Dec 19, 2024 | — |
| S-3 | Shelf registration | Aug 8, 2024 | — |
| S-8 | Employee stock plan registration | Dec 9, 2022 | — |
| 424B4 | Prospectus | Nov 16, 2020 | — |
| S-1/A | Amended registration statement | Nov 10, 2020 | — |
| S-1 | Registration statement | Oct 16, 2020 | — |
| 424B5 | Prospectus supplement | Nov 22, 2019 | — |
| 424B5 | Prospectus supplement | Nov 19, 2019 | — |
| S-3/A | Filing | Sep 16, 2019 | — |
| S-3 | Shelf registration | Sep 4, 2019 | — |
| 424B3 | Prospectus | Feb 14, 2019 | — |
| S-8 | Employee stock plan registration | Feb 11, 2019 | — |
| POS AM | Filing | Feb 11, 2019 | — |
| 424B3 | Prospectus | Feb 4, 2019 | — |
| S-3/A | S-3/a amendment no.2 | Jan 15, 2019 | — |
| S-3/A | Filing | Jan 10, 2019 | — |
| S-3 | Shelf registration | Dec 24, 2018 | — |
| 424B3 | Prospectus | Nov 30, 2018 | — |
| S-4/A | Filing | Nov 30, 2018 | — |
| S-4/A | Filing | Nov 28, 2018 | — |
| S-4/A | Filing | Nov 19, 2018 | — |
| S-4/A | Filing | Nov 5, 2018 | — |
| S-4/A | Filing | Oct 9, 2018 | — |
| S-4 | Registration for a merger or exchange | Aug 29, 2018 | — |
| S-4/A | Filing | Feb 12, 2018 | — |
| S-4/A | Filing | Feb 9, 2018 | — |
| S-4/A | Filing | Feb 5, 2018 | — |
| S-4/A | Filing | Jan 22, 2018 | — |
| S-4/A | Filing | Jan 19, 2018 | — |
| S-4/A | Filing | Jan 18, 2018 | — |
| S-4/A | Filing | Dec 26, 2017 | — |
| S-4 | Registration for a merger or exchange | Nov 22, 2017 | — |
| 424B4 | Prospectus | Oct 11, 2016 | — |
| S-1/A | Amended registration statement | Oct 7, 2016 | — |
| S-1/A | Amended registration statement | Sep 30, 2016 | — |
| S-1 | Registration statement | Sep 2, 2016 | — |
Showing 39 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ORGO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Canton, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1661181
- Former names
- Avista Healthcare Public Acquisition Corp. (until Dec 10, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.